补脾益肺汤治疗慢性阻塞性肺疾病稳定期（肺脾亏虚）的临床观察

《补脾益肺汤治疗慢性阻塞性肺疾病稳定期（肺脾亏虚）的临床观察》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、学校代号10199学号20125126065硕士学位论文补脾益肺汤治疗慢性阻塞性肺疾病稳定期（肺脾亏虚）的临床观察TheclinicalobservationofthestableofTonifyingspleen&benificiallungsouptotreatthechronicobstructivepulmonarydiseases(lungandspleenefficiency)学位申请人谢如东导师姓名职称仕丽副教授专业名称中西医结合临床研究方向中西医结合治疗肺病培养方式全日制申请学位类型专业学位论文提交日期2015年3月分类号密级ＵＤＣ编号硕士学位

2、论文补脾益肺汤治疗慢性阻塞性肺疾病稳定期（肺脾亏虚）的临床观察TheclinicalobservationofthestableofTonifyingspleen&benificiallungsouptotreatthechronicobstructivepulmonarydiseases(lungandspleenefficiency)谢如东指导教师姓名：仕丽副教授（长春中医药大学附属医院）申请学位级别：硕士专业名称：中西医结合临床研究方向：中西医结合治疗肺病论文提交日期：2015年4月论文答辩日期：2015年6月学位授予单位：长春中医药大学提交确认：作者签

3、名谢如东导师签名：仕丽长春中医药大学学位论文原创性声明本人郑重声明：所呈交的学位论文，是个人在导师的指导下，独立进行研究工作所取得的成果。除文中已经特另咖吹；主明引用的内容外，本论文不含任何其他个人或集体已经发表或撰写过的作品成果。对本文的研究做出重要贡献的个人和集体，均已在文中明确方式标明并致谢。本人完全意识到本声明的法律结果由本人承担。、作者签名马年月如ｉ支（化关于学位论文知识产权巧属的声明本人郑重声明；所呈交的学位论文，是本人在导师指导下自选课题或导师承担的国家立项资助一的计划课题的＾５分，系本人在导师指导和资助下独立

4、进行研究工作所取得的成果，知识产权归属一切法律责任由本人承担权为长春中医药大学和本人导师所有。特此声明，本声明的。＾作者签ｇ巧乐指导教师答名名＿＾Ｕ年月｜１曰＾＾关于学位论文使用授权的声巧本人完全了解长春中医药大学有关保留使用学位论文的规定，同意学校保留并向有关机胸送交论文的复印件和电子版查阅和借阅。本人授权长春中医药大学可１＾，化许被义搭本学位论文的全部或部分内容编入有关数据库进行检索，可ＬＵ采用影印、缩印或貫他复印手段保存和汇编本学位论文。（保密论文在解密后应遵守此规定）作者签名ｊ指导故师答名公而长春中医药大学

5、2015届硕士学位论文目录目录中文摘要·······························································································1英文摘要·······························································································2英文缩略语·······························································

6、·····························3前言·······························································································4一、文献综述·························································································5（一）现代医学对COPD的研究进展··········································

7、··················51、病因·····························································································52、发病机制·······················································································53、诊断····································································

8、···················